177 related articles for article (PubMed ID: 4581992)
1. [Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
Domingo Gutiérrez AJ; Fernández-Cruz A
Rev Iber Endocrinol; 1973; 20(117):289-303. PubMed ID: 4581992
[No Abstract] [Full Text] [Related]
2. Pharmacological and clinical evaluation of the activity and tolerance of a new oral antidiabetic compound, glydiazinamide or K 4024.
Parodi FA
Isr J Med Sci; 1972 Jun; 8(6):888-92. PubMed ID: 5051831
[No Abstract] [Full Text] [Related]
3. [Clinical trial of glypizide].
Cañadell Vidal J
Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
[No Abstract] [Full Text] [Related]
4. A controlled clinical trial of a new oral hypoglycemic agent, glipizide (K 4024).
Lentini S; Bossini A; Pirola LC
Arzneimittelforschung; 1972 Jul; 22(7):1169-73. PubMed ID: 4678124
[No Abstract] [Full Text] [Related]
5. Effect of glipizide on a double-meal test in diabetic patients.
Vailati G; Pagani G; Montini M; Caputo G; Sacchetti G
Arzneimittelforschung; 1972 Nov; 22(11):1888-9. PubMed ID: 4679061
[No Abstract] [Full Text] [Related]
6. [New oral hypoglycemic agent: K 4024 or glipizide. Clinical trial].
Angeli G; Baraldi B; Tiraboschi L; Caputo G
Clin Ter; 1972 Dec; 63(5):438-52. PubMed ID: 4566419
[No Abstract] [Full Text] [Related]
7. [Treatment of diabetes with low doses of glypizide].
Lozano-Castañeda O; Schulte J; Gonzálex Barranco J; García Viveros M; Rull JA
Prensa Med Mex; 1974; 39(7-8):358-61. PubMed ID: 4453534
[No Abstract] [Full Text] [Related]
8. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].
Villaseñor A
Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089
[No Abstract] [Full Text] [Related]
9. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
D'Onofrio F; Pempinello R; Romis L
Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
[No Abstract] [Full Text] [Related]
10. [Clinical experimentation with a new hypoglycemic agent (glipizide)].
Forattini C
Minerva Med; 1972 Oct; 63(70):3816-21. PubMed ID: 4562437
[No Abstract] [Full Text] [Related]
11. [Evaluation of a new sulfonylurea, glipizide, in the treatment of diabetes mellitus].
Ninni M; Castelletta L
Minerva Med; 1973 Oct; 64(71):3725-31. PubMed ID: 4588364
[No Abstract] [Full Text] [Related]
12. [Clinical trial of a new oral antidiabetic: glypizide].
Paes E; Gomes FJ; Pinto RE; De Alburquerque MA; Farinha H
Rev Iber Endocrinol; 1974; 21(125):459-62, 466-6, 469-70 passim. PubMed ID: 4422452
[No Abstract] [Full Text] [Related]
13. Modifications of glycemia and insulinemia in diabetics treated with glipizide (K 4024), a new sulfonylurea.
Fedele D; Tiengo A; Riva F; Muggeo M; Emanueli A; Crepaldi G
Arzneimittelforschung; 1972 Nov; 22(11):1885-8. PubMed ID: 4679060
[No Abstract] [Full Text] [Related]
14. [Glydiazinamide-induced changes in the oral glucose tolerance of 15 adult diabetics].
Vailati G; Montini M; Pagani G; Caputo G
Minerva Med; 1972 Oct; 63(69):3752-7. PubMed ID: 5078667
[No Abstract] [Full Text] [Related]
15. Glipizide, a new oral antidiabetic agent (report of a controlled clinical study in Sweden).
Johannessen A; Fagerberg SE
Diabetologia; 1973 Sep; ():339-47. PubMed ID: 4589634
[No Abstract] [Full Text] [Related]
16. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
Emanueli A; Molari E; Pirola LC; Caputo G
Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
[No Abstract] [Full Text] [Related]
17. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
Pou Torelló JM; Vilaclara JM
Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
[No Abstract] [Full Text] [Related]
18. Clinical study with glipizide, a new oral antidiabetic drug.
Persson G
Diabetologia; 1973 Sep; ():348-50. PubMed ID: 4589635
[No Abstract] [Full Text] [Related]
19. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
Vernet A; Fabre J; Zahnd G
Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
[No Abstract] [Full Text] [Related]
20. [Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
Calvet JM; Matarrodona M; Bordas R
Rev Iber Endocrinol; 1974; 21(124):347-62. PubMed ID: 4453782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
